LENZ Therapeutics Inc. Company Profile
NASDAQ: LENZHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD
3.53-0.09 (-2.49%)
At close: Oct 8, 4:00 PM ET · Delayed 15 min
After hours: 3.53 0.00%
LENZ Therapeutics at a glance
LENZ Therapeutics Inc. (NASDAQ: LENZ) is a Biotechnology: Biological Products (No Diagnostic Substances) company in the Health Care sector. The company's shares have traded publicly since 2021. At a market capitalization of $113.7 million, it is considered a small-cap company.
Its SEC Central Index Key (CIK) is 0001815776, which identifies the company's filings on EDGAR.
Summary generated from market data by MetaCap's automated system. Methodology
Company information
- Legal name
- LENZ Therapeutics Inc.
- Ticker
- NASDAQ: LENZ
- Sector
- Health Care
- Industry
- Biotechnology: Biological Products (No Diagnostic Substances)
- Headquarters
- United States
- IPO year
- 2021
- Market cap
- $113.74M
- SEC CIK
- 0001815776
Companies similar to LENZ Therapeutics
| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| ENGNenGene Therapeutics Inc. | 1.78 | +2.01% | $119.29M | vs LENZ |
| TNYATenaya Therapeutics Inc. | 0.5442 | +2.02% | $122.03M | vs LENZ |
| BDTXBlack Diamond Therapeutics Inc. | 1.81 | -1.09% | $103.72M | vs LENZ |
| HUMAHumacyte Inc. | 0.4471 | -5.34% | $124.20M | vs LENZ |
| ATRAAtara Biotherapeutics Inc. | 9.23 | -1.49% | $92.65M | vs LENZ |
| OTLKOutlook Therapeutics Inc. | 0.564 | -4.41% | $137.30M | vs LENZ |
| NMRANeumora Therapeutics Inc. | 0.4798 | +2.46% | $90.15M | vs LENZ |
| CGTXCognition Therapeutics Inc. | 0.8952 | -4.42% | $85.13M | vs LENZ |